Chairs:
Andreas du Bois, MD, PhD
Dr. Horst-Schmidt-Kliniken
Wiesbaden, Germany
Eric Pujade-Lauraine, MD, PhD
Centre Hospitalier Universitaire Hotel-Dieu
Paris, France
Faculty:
Xavier Bosch, MD, PhD
Institut Catala d'Oncologia
Barcelona, Spain
Andrew Clamp, MD, PhD
Cancer Research UK, Christie Hospital,
United Kingdom
Phillip Harter, MD
Dr. Horst Schmidt Klinik,
Wiesbaden, Germany
Stanley B. Kaye, MD
The Royal Marsden Hospital & Institute of Cancer Research
Sutton, United Kingdom
Fabrice Lécuru, MD, PhD
Hôpital Européen Georges Pompidou
Paris, France
Mansoor R. Mirza, MD
Rigshopitalet, Copenhagen University Hospital
Copenhagen, Denmark
Jacobus Pfisterer, MD, PhD
Hospital Solingen
Germany
Sandro Pignata, MD, PhD
Istituto Nazionale Tumori
Napoli, Italy
Gordon J.S. Rustin, MD, FRCP
The Clocktower Mount Vernon Hospital
Northwood, United Kingdom
Ignace Vergote, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium
Friday, 12 February 2010
11.30
Registration and lunch
13.00
Welcome and introduction
Session I:
Cervical Cancer
13.05
Interactive oncology challenge
13.10
Strategies for cervical cancer prevention
13.40
New concepts in the staging of cervical cancer
14.10
Interactive clinical case: Locally advanced stage cervical carcinoma: Evaluating the options
14.40
Break
Session II:
Ovarian Cancer I: Surgery and First-Line Therapy
15.10
Interactive oncology challenge
15.15
State of the art surgical strategies in ovarian cancer: How to do it?
15.45
State of the art surgical strategies in ovarian cancer: When to do it?
16.15
Interactive clinical case: First-line systemic therapies for ovarian cancer
16.45
Definition and characterization of low-grade and high-grade ovarian serous carcinomas
17.15
Adjourn
17.30
Reception
Saturday, 13 February 2010
07.30
Breakfast
09.00
Welcome and introduction
Session III:
Endometrial Cancer
09.05
Interactive oncology challenge
09.10
State of the art surgical and radiotherapy strategies in endometrial carcinoma
09.40
Interactive clinical case: Systemic therapy for endometrial cancer: A new standard?
10.10
Break
Session IV:
Ovarian Cancer II: A Case-Based Approach to Recurrence
10.40
Interactive oncology challenge
10.45
Interactive clinical case: non surgical Management of platinum sensitive ovarian cancer
11.15
Interactive clinical case: Considerations for the management of a partially platinum sensitive relapse (6-12 months)
11.45
Interactive clinical case: Management of platinum resistant/refractory ovarian cancer
12.15
Lunch
13.30
Keynote Lecture:
Changing standards of care: The role of CA125 in the management of Ovarian Cancer
Session V:
Ovarian Cancer III: Novel Therapies
14.15
Interactive oncology challenge
14.20
Emerging options in antiangiogenic targeted therapy for ovarian cancer
14.50
Targeted therapy for ovarian cancer: Beyond angiogenesis
15.20
Oncology challenge results
15.25
Concluding remarks
15.30
Adjourn